Novo Nordisk , the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to ...

While Pfizer's market cap and dividends are at risk, Novo has a strong competitive position in GLP-1 TAM. Read why I prefer ...

Leading global health care company Novo Nordisk is stepping up efforts to curb the climbing obesity incidence in the country as it recently formalized its partnership with Watsons Philippines to make ...

Wegovy-maker Novo Nordisk said on Thursday it had told all its staff to return to the office as the drugmaker's new CEO tries ...

Novo Nordisk leads globally in GLP-1s despite U.S. pressure, with a strong pipeline, cost cuts, and attractive valuation.

The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and ...

If you’re eyeing Novo Nordisk stock right now, you’re not alone. Investors have been left scratching their heads as to what comes next, after several twists in the company’s share price. In the past ...

Wall Street's major averages closed mixed on Friday, with the Nasdaq Composite (COMP:IND) closing at new highs every day of the week, while the Dow (DJI) retreated from the 46k level. The Nasdaq ...